HOUSTON--(BUSINESS WIRE)--Emerging Healthcare Solutions (PinkSheets: EHSI) subsidiary Celulas Genetica advanced its goal to test a breakthrough stem cell procedure in China today by engaging influential Chinese attorney Zhang Yan of the Longan Law Firm. The move successfully completes a nationwide search for a qualified negotiator to secure a proton-beam facility for testing and analysis of the Rutherford Procedure, a new medical treatment aimed at repairing the human liver and decreasing the need for liver transplants worldwide.
